DGLUCY Antibody (C-7): sc-515311
- DGLUCY Antibody (C-7) is a mouse monoclonal IgG1 κ DGLUCY antibody provided at 200 µg/ml
- specific for an epitope mapping between amino acids 207-234 within an internal region of DGLUCY of mouse origin
- DGLUCY Antibody (C-7) is recommended for detection of DGLUCY of mouse and rat origin by WB, IP, IF and ELISA
- Anti-DGLUCY Antibody (C-7) is available conjugated to agarose for IP; HRP for WB, IHC(P) and ELISA; and to either phycoerythrin or FITC for IF, IHC(P) and FCM
- also available conjugated to Alexa Fluor® 488, Alexa Fluor® 546, Alexa Fluor® 594 or Alexa Fluor® 647 for WB (RGB), IF, IHC(P) and FCM, and for use with RGB fluorescent imaging systems, such as iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
- also available conjugated to Alexa Fluor® 680 or Alexa Fluor® 790 for WB (NIR), IF and FCM; for use with Near-Infrared (NIR) detection systems, such as LI-COR®Odyssey®, iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
- m-IgG Fc BP-HRP, m-IgG1 BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for DGLUCY Antibody (C-7) for WB applications. These reagents are now offered in bundles with DGLUCY Antibody (C-7) (see ordering information below).
QUICK LINKS
SEE ALSO...
DGLUCY Antibody (C-7) is a mouse monoclonal IgG1 kappa light chain antibody that detects DGLUCY protein of mouse and rat origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). anti-DGLUCY antibody (C-7) is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates, providing versatility for different experimental needs. DGLUCY protein plays a crucial role in glucose metabolism and is involved in energy homeostasis regulation, making DGLUCY (C-7) antibody significant for understanding metabolic disorders and potential therapeutic targets. DGLUCY protein′s proper function is essential for maintaining glucose levels in the body, and dysregulation can lead to conditions such as diabetes and obesity. DGLUCY protein is primarily located in the cytoplasm, where DGLUCY (C-7) monoclonal antibody can detect interactions with various metabolic pathways, underscoring DGLUCY′s importance in cellular energy management. Using anti-DGLUCY antibody (C-7) in research can provide valuable insights into glucose metabolism mechanisms and their implications in health and disease.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
DGLUCY Antibody (C-7) References:
- The DNA sequence and analysis of human chromosome 14. | Heilig, R., et al. 2003. Nature. 421: 601-7. PMID: 12508121
- A presenilin 1 R278I mutation presenting with language impairment. | Godbolt, AK., et al. 2004. Neurology. 63: 1702-4. PMID: 15534260
- Pathological and physiological functions of presenilins. | Vetrivel, KS., et al. 2006. Mol Neurodegener. 1: 4. PMID: 16930451
- Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population. | Albani, D., et al. 2007. Neurobiol Aging. 28: 1682-8. PMID: 16952411
- Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies. | Micci, F., et al. 2007. Virchows Arch. 450: 559-65. PMID: 17406891
- A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. | Martín-Subero, JI., et al. 2007. Leukemia. 21: 1532-44. PMID: 17495977
- The genetics of very early onset Alzheimer disease. | Filley, CM., et al. 2007. Cogn Behav Neurol. 20: 149-56. PMID: 17846513
- The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency. | Cruz, PE., et al. 2007. Pharmacogenomics. 8: 1191-8. PMID: 17924834
- Alpha1-antitrypsin deficiency: current perspective on research, diagnosis, and management. | Stolk, J., et al. 2006. Int J Chron Obstruct Pulmon Dis. 1: 151-60. PMID: 18046892
- Harmine suppresses collagen production in hepatic stellate cells by inhibiting DYRK1B. | Yamaguchi, M., et al. 2022. Biochem Biophys Res Commun. 600: 136-141. PMID: 35219102
- Roles of dual specificity tyrosine-phosphorylation-regulated kinase 2 in nervous system development and disease. | Santos-Durán, GN. and Barreiro-Iglesias, A. 2022. Front Neurosci. 16: 994256. PMID: 36161154
- Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer? | Liu, CC. and Wang, XS. 2023. Oncotarget. 14: 595-596. PMID: 37306551
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DGLUCY Antibody (C-7) | sc-515311 | 200 µg/ml | $322.00 | |||
DGLUCY Antibody (C-7): m-IgG Fc BP-HRP Bundle | sc-531334 | 200 µg Ab; 10 µg BP | $361.00 | |||
DGLUCY Antibody (C-7): m-IgGκ BP-HRP Bundle | sc-524998 | 200 µg Ab, 40 µg BP | $361.00 | |||
DGLUCY Antibody (C-7): m-IgG1 BP-HRP Bundle | sc-544490 | 200 µg Ab; 20 µg BP | $361.00 | |||
DGLUCY Antibody (C-7) AC | sc-515311 AC | 500 µg/ml, 25% agarose | $424.00 | |||
DGLUCY Antibody (C-7) HRP | sc-515311 HRP | 200 µg/ml | $322.00 | |||
DGLUCY Antibody (C-7) FITC | sc-515311 FITC | 200 µg/ml | $336.00 | |||
DGLUCY Antibody (C-7) PE | sc-515311 PE | 200 µg/ml | $349.00 | |||
DGLUCY Antibody (C-7) Alexa Fluor® 488 | sc-515311 AF488 | 200 µg/ml | $364.00 | |||
DGLUCY Antibody (C-7) Alexa Fluor® 546 | sc-515311 AF546 | 200 µg/ml | $364.00 | |||
DGLUCY Antibody (C-7) Alexa Fluor® 594 | sc-515311 AF594 | 200 µg/ml | $364.00 | |||
DGLUCY Antibody (C-7) Alexa Fluor® 647 | sc-515311 AF647 | 200 µg/ml | $364.00 | |||
DGLUCY Antibody (C-7) Alexa Fluor® 680 | sc-515311 AF680 | 200 µg/ml | $364.00 | |||
DGLUCY Antibody (C-7) Alexa Fluor® 790 | sc-515311 AF790 | 200 µg/ml | $364.00 | |||
DGLUCY (C-7) Neutralizing Peptide | sc-515311 P | 100 µg/0.5 ml | $69.00 |